Overview

Safety and Efficacy of Empagliflozin in GSD1b Patients With Neutropenia

Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
Treatment of neutropenia of Glycogenosis type 1b patients with empagliflozin
Phase:
Phase 2
Details
Lead Sponsor:
Children's Memorial Health Institute, Poland
Collaborator:
Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsaw
Treatments:
Empagliflozin